Posted in | News | Energy

Shin-Etsu Completes Netherlands PVC Plant Expansion

Shin-Etsu Chemical Co., Ltd. has announced that it has completed its expansion of the facilities of Shin-Etsu PVC B.V.,* in The Netherlands (President, Fumio Arai), the Shin-Etsu Group’s European production and sales base for PVC, and full-scale operation has begun. This expansion increased the production capacity of Shin-Etsu PVC’s Pernis Plant (near Rotterdam) from 350,000 to 450,000 tons/year, and it was completed earlier than the scheduled completion date of October 2006. The investment amount for this expansion was about €50 million (about 7.5 billion yen).

This plant expansion was carried out in anticipation of strong growing demand for PVC in Europe in the future for such PVC application areas as in pipes used for water and sewage systems, as well as in applications for such products as window frames that require insulation properties as an energy-saving measure. Previously, Shin-Etsu PVC expanded its VCM (vinyl chloride monomer) production capacity from 500,000 to 620,000 tons/year in November 2003.

Shin-Etsu Chemical is producing PVC using a tripolar production structure -- the U.S., Europe and Japan -- and its total global production capacity has now reached 3.24 million tons with Shin-Etsu PVC’s expansion in capacity.

Shin-Etsu is currently constructing large-scale integrated PVC manufacturing facilities, from electrolysis to VCM, and to PVC, in the State of Louisiana, in the U.S., which will increase its U.S. Group company Shintech’s PVC production capacity from 2.04 million to 2.64 million tons/year.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.